Lucrin Depot Paediatric Prefilled
dual chamber syringe (pds)
Injection 3 Month (leuprorelin
acetate) is a synthetic
nonapeptide analogue of naturally
occurring gonadotropin releasing
hormone (GnRH or LH‑RH). Lucrin
Depot Paediatric PDS Injection 3
Month is indicated in the treatment
of children with central precocious
puberty (CPP). Although not
expected to be relevant to the
approved indication, Lucrin
Depot Paediatric PDS Injection
3 Month is contraindicated
when the patient is pregnant
or may become pregnant due
to embryotoxic effects and in
nursing mothers. Lucrin Depot
Paediatric PDS Injection 3 Month
is available as a 30 mg single dose
procedure pack of a dual chamber
syringe containing sterile lyophilised
microspheres of leuprorelin acetate
in the front chamber and 1.5 mL of
diluent in the rear chamber.The above article was sent to subscribers in Pharmacy Daily's issue from 06 Jul 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Jul 15
THE Senate’s Community Affairs Legislation Committee is holding a two-day inquiry into the Therapeutic Goods and Other Legislation Amendment (Vaping Reforms) Bill 2024, which is currently under discussion in Federal Parliament.
A NEW study from the University of South Australia has discovered that an increased cardio-fitness level will reduce risk of death from any cause by nearly 20%.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.